Ophthalmoscope Market Analysis

  • Report ID: 3999
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Ophthalmoscope Market Segmentation:

Application Segment Analysis

The diabetes segment is estimated to hold 45% share of the global ophthalmoscope market in the coming years owing to the increasing cases of diabetes-induced blindness around the world. Patients suffering from diabetes have affected retina which can lead to blindness. This as a result rises the demand for ophthalmoscopes as it helps in the on-time detection and diagnosis of the disease. As per recent reports, diabetic retinopathy is accountable for nearly 4.5 % of blindness cases across the globe. By 2030, there will be around 640 million diabetics worldwide, and by 2045, the figure is expected to rise to over 78o million.

End- Users Segment Analysis

Ophthalmoscope market from the hospital segment is set to garner a notable gain in the near future. The growth of the segment is driven by the rising usage of ophthalmoscopes. Owing to the growing awareness of eye-related diseases more and more people are visiting hospitals that offer ophthalmic services to seek timely diagnosis and help in the management of eye-related conditions. This, as a result, has increased the demand for ophthalmoscopes on the hospital premises.

Our in-depth analysis of the global market includes the following segments:

     By End-User

  • Hospitals
  • Eye Clinics

     By Application

  • Glaucoma
  • Retinal Tear
  • Diabetes

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of ophthalmoscope is evaluated at USD 312.8 million.

The global ophthalmoscope market size was worth more than USD 295.01 million in 2025 and is poised to witness a CAGR of over 6.7%, crossing USD 564.26 million revenue by 2035.

North America ophthalmoscope market is predicted to capture 37% share by 2035, driven by increasing health awareness and demand for eye diagnostics.

Key players in the market include Medline Industries, LP, Eli Lilly and Company, Bausch & Lomb Incorporated, Sun Pharmaceutical Industries Ltd., Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Merck & Co., Inc., Siemens Healthcare GmbH, Pfizer Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos